Screening and replication using the same data set: testing strategies for family-based studies in which all probands are affected.
For genome-wide association studies in family-based designs, we propose a powerful two-stage testing strategy that can be applied in situations in which parent-offspring trio data are available and all offspring are affected with the trait or disease under study. In the first step of the testing strategy, we construct estimators of genetic effect size in the completely ascertained sample of affected offspring and their parents that are statistically independent of the family-based association/transmission disequilibrium tests (FBATs/TDTs) that are calculated in the second step of the testing strategy. For each marker, the genetic effect is estimated (without requiring an estimate of the SNP allele frequency) and the conditional power of the corresponding FBAT/TDT is computed. Based on the power estimates, a weighted Bonferroni procedure assigns an individually adjusted significance level to each SNP. In the second stage, the SNPs are tested with the FBAT/TDT statistic at the individually adjusted significance levels. Using simulation studies for scenarios with up to 1,000,000 SNPs, varying allele frequencies and genetic effect sizes, the power of the strategy is compared with standard methodology (e.g., FBATs/TDTs with Bonferroni correction). In all considered situations, the proposed testing strategy demonstrates substantial power increases over the standard approach, even when the true genetic model is unknown and must be selected based on the conditional power estimates. The practical relevance of our methodology is illustrated by an application to a genome-wide association study for childhood asthma, in which we detect two markers meeting genome-wide significance that would not have been detected using standard methodology.
Murphy
Amy
A
Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Weiss
Scott T
ST
Lange
Christoph
C
D001249:Asthma / Q000235:genetics*; D002648:Child; D003198:Computer Simulation; D005190:Family; D005260:Female; D005819:Genetic Markers; D005820:Genetic Testing; D005826:Genetics, Medical / Q000379:methods*; D005828:Genetics, Population / Q000379:methods*; D015894:Genome, Human; D006801:Humans; D008297:Male; D008957:Models, Genetic; D015233:Models, Statistical; D010375:Pedigree; D020641:Polymorphism, Single Nucleotide; D019655:Quantitative Trait, Heritable
D005819:Genetic Markers